Target intelligence / Profile preview

Extracellular matrix protein of the natural bovine bone matrix scaffold and autologous graft (ECM protein (NBBM/Autograft))

Target
ECM protein (NBBM/Autograft)
Molecular classification
Structural protein, Glycoprotein, Proteoglycan, Other
01

Overview

The extracellular matrix (ECM) proteins of the Natural Bovine Bone Matrix (NBBM) scaffold and autologous grafts represent a complex assembly of structural and bioactive molecules essential for bone regeneration. These proteins, primarily including Type I collagen, osteocalcin, and bone sialoprotein, provide the necessary architecture and biochemical cues for osteoblast adhesion, proliferation, and differentiation (UniProt: P02452; PubMed: 32824342). In clinical practice, NBBM serves as an osteoconductive scaffold that maintains space and supports new bone formation in dental and orthopedic procedures, such as ridge augmentation and sinus lifts. Autologous grafts complement this by providing osteoinductive growth factors, such as bone morphogenetic proteins (BMPs), and living osteogenic cells, which significantly enhance the overall regenerative potential compared to synthetic alternatives (StatPearls: NBK537071). While not a single drug target, these proteins interact with cellular receptors like integrins to trigger intracellular signaling pathways conducive to tissue repair. Understanding the composition of these matrices is crucial for optimizing bone grafting outcomes and developing next-generation biomimetic scaffolds in the field of regenerative medicine.

Other names
Bone matrix proteinsNBBM proteinsAutograft extracellular matrixNatural bovine bone mineral proteins
02

Mechanism of action

Provides an osteoconductive framework and biochemical signals that facilitate the attachment, migration, and differentiation of osteogenic cells through integrin-mediated signaling (Bousnaki et al., 2020; PubMed: 32824342).

03

Biological functions

Cell adhesionCell proliferationCell differentiationOsteogenesisMineralizationOther
04

Disease associations

Bone lossPeriodontitisAlveolar ridge resorptionBone fracturesOther
05

Safety considerations

ImmunogenicityRisk of disease transmission (bovine source)Graft resorption or failureInfection at the donor or recipient site
06

Interacting drugs

Recombinant human bone morphogenetic protein-2 (rhBMP-2)

3 more in the full profile.

07

Biomarkers

Osteocalcin (BGLAP)Alkaline phosphatase (ALPL)Type I collagen C-telopeptide (CTX-1)Procollagen type I N-terminal propeptide (PINP)

Beyond the preview

Go deeper on Extracellular matrix protein of the natural bovine bone matrix scaffold and autologous graft (ECM protein (NBBM/Autograft)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix protein of the natural bovine bone matrix scaffold and autologous graft (ECM protein (NBBM/Autograft)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call